Treatment of Bulimia Nervosa in a Primary Care Setting
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
Bulimia Nervosa is a frequent problem for young women. It is widely assumed that this disorder cannot be treated effectively in a primary care setting. This assumption has never been tested empirically, and is probably incorrect. In the last 15 years, effective treatment interventions for Bulimia Nervosa have been developed and validated in specialized treatment centers. The broad aim of this proposal is to examine whether these treatments, suitably adapted, can be usefully transferred to general health care settings. Specifically, the proposed study will determine the relative and combined effectiveness of the two leading treatments for Bulimia Nervosa in a primary care setting. The two major interventions are treatment with an antidepressant medication, fluoxetine, and with a form of cognitive behavioral therapy, guided self-help, designed for use in primary care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Mar 1998
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 1998
CompletedFirst Submitted
Initial submission to the registry
January 23, 2001
CompletedFirst Posted
Study publicly available on registry
January 23, 2001
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2001
CompletedJanuary 14, 2010
January 1, 2010
January 23, 2001
January 12, 2010
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- DSM-IV criteria for bulimia nervosa with a modified frequency criterion of at least once a week
You may not qualify if:
- Physical disorder requiring hospitalization or ongoing treatment likely to affect eating and/or weight
- Significant suicidal ideation or behavior
- Subjects judged unable to tolerate four-month treatments available in the study because of comorbid psychiatric conditions
- Current drug or alcohol dependence
- Current anorexia nervosa
- Pregnancy or any physical condition or treatments known to influence eating and weight
- Current psychiatric treatment or medication known to affect eating or weight
- Previous course of fluoxetine at a dose of 60 mg. per day for at least four weeks
- Allergy to fluoxetine
- Previous course of cognitive behavioral therapy for Bulimia Nervosa at a qualified center
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
New York State Psychiatric Institute
New York, New York, 10032, United States
Related Publications (1)
Waller D, Fairburn CG, McPherson A, Kay R, Lee A, Nowell T. Treating bulimia nervosa in primary care: a pilot study. Int J Eat Disord. 1996 Jan;19(1):99-103. doi: 10.1002/(SICI)1098-108X(199601)19:13.0.CO;2-L.
PMID: 8640208BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
B. T. Walsh, MD
Columbia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- NIH
Study Record Dates
First Submitted
January 23, 2001
First Posted
January 23, 2001
Study Start
March 1, 1998
Study Completion
December 1, 2001
Last Updated
January 14, 2010
Record last verified: 2010-01